Ms. magazine  -- more than a magazine a movement

SIGN UP FOR MS. DIGEST, JOBS, NEWS AND ALERTS

FEMINIST WIRE NEWSBRIEFS

ABOUT
SEE CURRENT ISSUE
SHOP MS. STORE
MS. IN THE CLASSROOM
FEMINIST DAILY WIRE
FEMINIST RESOURCES
PRESS
JOBS AT MS.
READ BACK ISSUES
CONTACT
RSS (XML)
 
feminist wire | daily newsbriefs

May-05-04

FDA Approval of Over-the-Counter Emergency Contraception Uncertain

Barr Laboratories, distributors of the emergency contraceptive Plan B, are reportedly concerned that the Food and Drug Administration (FDA) will not approve their proposal to make the drug available without a prescription. Carole Ben-Maimon, president of Barr Laboratories' research division, told the Washington Post that she thinks “an approval is not a likely scenario." An overwhelming majority of expert FDA advisory panel members agreed in a December meeting that emergency contraception (EC) is safe, effective and meets all the requirements for over-the-counter status.

The medical community and women’s rights and health advocates accuse the FDA of succumbing to a vocal minority of right-wing political pressure and disregarding science in their decision to postpone the final ruling until May 21. In a statement issued yesterday, the American College of Obstetricians and Gynecologists (ACOG) and Physicians for Reproductive Choice and Health urged that “politics should not trump medical evidence for making Plan B available over-the-counter.”

Feminist Majority Foundation Medical Director Beth Jordan, MD concurred: “This decision should be made on scientific merit, not politics. The safety and efficacy of EC has never been in question and to deny women unrestricted over-the-counter access is simply unacceptable from a public health standpoint.”

EC is up to 95 percent effective in preventing pregnancy if taken within 24 hours after unprotected sex, failed contraception, or rape. It is safer than aspirin, meets all of the FDA's requirements for over the counter status, and has the potential to prevent 800,000 abortions in the United States annually.

“The voices of a vocal majority make an enormous difference,” says Dr. Jordan. “Join the majority of Americans who support over-the-counter access to EC and immediately urge the FDA to follow the advice of its own expert advisory panel, stop playing politics with women’s lives, and make emergency contraception available over the counter.”

TAKE ACTION Tell the FDA to Approve Emergency Contraception Over the Counter

DONATE to support FMF’s work to win over-the-counter status for emergency contraception

Media Resources: Philadelphia Inquirer 5/5/04; The Washington Post 5/5/04; Feminist Daily News Wire 2/19/04, 4/12/04


© Feminist Majority Foundation, publisher of Ms. magazine

If you liked this story, consider making a tax-deductible donation to support Ms. magazine.

 

 

Send to a Friend
Their
Your
Comments
(optional)


More Feminist News

4/18/2014 Texas Hospitals Revoke Admitting Privileges to Abortion Providers - Reproductive health access in Texas continues to vanish in the wake of HB 2, the omnibus anti-abortion bill that, among other things, requires abortion providers to have admitting privileges in order to keep their clinics open. . . .
 
4/18/2014 Dartmouth President Calls For Changes In Wake of Federal Sexual Assault Investigation - Dartmouth College President Phil Hanlon gave a powerful speech Wednesday night calling for significant changes on campus in light of its high rates of sexual assault, high-risk drinking, and discriminatory social scene. "Darmouth's promise is being hijacked by high-risk and harmful behaviors, behaviors that are hurting too many of our students, dividing us as a community and distracting from our important work of teaching and learning," Hanlon said. . . .
 
4/17/2014 Federal Court Permanently Blocks North Dakota's Extreme 6-Week Abortion Ban - A federal district court permanently blocked one of the most restrictive abortion bans in the nation yesterday, calling it "invalid and unconstitutional." The North Dakota law, HB 1456, directly challenged Roe v. . . .